Argenx shrugs off myasthenia gravis threat from UCB as Vyvgart nears next potential launch fkansteiner Thu, 05/09/2024 - 16:40

Bayer’s Midol unveils PeriodTalk campaign to ramp up conversations, education about menstruation apark Thu, 05/09/2024 - 12:09

In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts kdunleavy Thu, 05/09/2024 - 11:15

Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations fkansteiner Thu, 05/09/2024 - 11:36

As Vyvanse generics bite, Takeda sets out on $900M restructuring plan zbecker Thu, 05/09/2024 - 11:28

Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer fkansteiner Thu, 05/09/2024 - 10:45